We are live on
!
Find out more
I2I
Insight 2811 Inc Portfolio holdings
AUM
$259M
1-Year Est. Return
14.87%
This Fund
S&P 500
This Quarter
Est. Return
-0.8%
1 Year Est. Return
+14.87%
3 Year Est. Return
+30.77%
5 Year Est. Return
+30.52%
10 Year Est. Return
+95.19%
AUM
$233M
AUM Growth
-$5.76M
(-2.4%)
Cap. Flow
-$2.65M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
63.61%
Holding
178
New
65
Increased
29
Reduced
48
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.88M |
| 2 |
Apple
AAPL
|
+$866K |
| 3 |
RDC
Rowan Companies Plc
RDC
|
+$755K |
| 4 |
Walmart Inc
WMT
|
+$712K |
| 5 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$611K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$3.03M |
| 2 |
Prologis
PLD
|
+$2.94M |
| 3 |
Pentair
PNR
|
+$1.57M |
| 4 |
DNR
Denbury Resources, Inc.
DNR
|
+$772K |
| 5 |
BRFS
BRF SA
BRFS
|
+$733K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.16% |
| 2 | Financials | 15.52% |
| 3 | Energy | 8.06% |
| 4 | Technology | 4.21% |
| 5 | Consumer Staples | 3.88% |
Similar funds
CSA
EWM
PEWA
HFO
PWG
RWS
M1FG
BPCM
Insight 2811 Inc's Q3 2014 Portfolio in Review
As of Q3 2014, Insight 2811 Inc held 178 positions worth $233M, down 2.4% from $239M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Insight 2811 Inc's Q3 2014 filing shows 65 new, 29 increased, 48 reduced and 7 closed positions. Its largest new stake was Rowan Companies Plc: 25,600 shares worth $648K. The largest sale was GSK, an estimated $3.03M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 54% a quarter earlier, followed by Financials and Energy.
- Insight 2811 Inc's largest Q3 2014 buy was Rowan Companies Plc: 25,600 shares worth $648K.
- Insight 2811 Inc added most to Vanguard Short-Term Corporate Bond ETF in Q3 2014, an estimated $1.88M increase.
- Insight 2811 Inc's biggest Q3 2014 reduction was Prologis, cutting an estimated $2.94M.
- Insight 2811 Inc fully exited GSK in Q3 2014, selling an estimated $3.03M.
- Insight 2811 Inc's ten largest holdings make up 64% of its $233M portfolio in Q3 2014.
- Insight 2811 Inc opened 65 new positions and closed 7 in Q3 2014.
- Insight 2811 Inc's portfolio value fell 2.4% quarter-over-quarter to $233M.
Based on Insight 2811 Inc's 13F filing for Q3 2014, filed 14 Nov 2014.